Differential regulation of CDX1 and CDX2 gene expression by deficiency in methyl group donors

Biochimie

Volumn 90, Issue 5, 2008, Pages 697-704

  Lu, Xiaohong ^a,b   Freund, Jean Noël ^a,c   Muller, Marc ^a,b   Ravey, Juliette ^a,b   Nicolas, Jean Pierre ^a,b   Gueant, Jean Louis ^a,b   Namour, Farès ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

CDX1; CDX2; DNA methylation; Folate methyl group deficiency; Histone modifications

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CHOLINE; CYANOCOBALAMIN; FOLIC ACID; HISTONE DEACETYLASE; METHYL GROUP; RIBOFLAVIN; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR CDX2; VORINOSTAT;

ANIMAL EXPERIMENT; ARTICLE; CANCER PREVENTION; CELL STRAIN CACO 2; CELL STRAIN HT29; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; COLORECTAL CANCER; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; FEMALE; FOLIC ACID DEFICIENCY; GENE EXPRESSION; HOMEOBOX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BASE SEQUENCE; CACO-2 CELLS; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HT29 CELLS; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 42649117164     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2007.12.002     Document Type: Article

References (33)

1. Kim Y.I. Role of folate in colon cancer development and progression. J. Nutr. 133 (2003) 3731S-3739S
2. Sanjoaquin M.A., Allen N., Couto E., Roddam A.W., and Key T.J. Folate intake and colorectal cancer risk: a meta-analytical approach. Int. J. Cancer 113 (2005) 825-828
3. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J. Nutr. 132 (2002) 2350S-2355S
4. Kim Y.I. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J. Nutr. 135 (2005) 2703-2709
5. Sharp L., and Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am. J. Epidemiol. 159 (2004) 423-443
6. Le Marchand L., Wilkens L.R., Kolonel L.N., and Henderson B.E. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study, Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1198-1203
7. Van Guelpen B., Hultdin J., Johansson I., Hallmans G., Stenling R., Riboli E., Winkvist A., and Palmqvist R. Low folate levels may protect against colorectal cancer. Gut 55 (2006) 1461-1466
8. Beck F., Chawengsaksophak K., Waring P., Playford R.J., and Furness J.B. Reprogramming of intestinal differentiation and intercalary regeneration in cdx2 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7318-7323
9. Bonhomme C., Duluc I., Martin E., Chawengsaksophak K., Chenard M.P., Kedinger M., Beck F., Freund J.N., and Domon-Dell C. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 52 (2003) 1465-1471
10. Lorentz O., Duluc I., de Arcangelis A., Simon-Assmann P., Kedinger M., and Freund J.N. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J. Cell Biol. 139 (1997) 1553-1565
11. Soubeyran P., Andre F., Lissitzky J.C., Mallo G.V., Moucadel V., Roccabianca M., Rechreche H., Marvaldi J., Dikic I., Dagorn J.C., and Iovanna J.L. Cdx1 promotes differentiation in a rat intestinal epithelial cell line. Gastroenterology 117 (1999) 1326-1338
12. Suh E., and Traber P.G. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol. Cell. Biol. 16 (1996) 619-625
13. Ee H.C., Erler T., Bhathal P.S., Young G.P., and James R.J. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am. J. Pathol. 147 (1995) 586-592
14. Hinoi T., Tani M., Lucas P.C., Caca K., Dunn R.L., Macri E., Loda M., Appelman H.D., Cho K.R., and Fearon R. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am. J. Pathol. 159 (2001) 2239-2248
15. Kaimaktchiev V., Terracciano L., Tornillo L., Spichtin H., Stoios D., Bundi M., Korcheva V., Mirlacher M., Loda M., Sauter G., and Corless C.L. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod. Pathol. 17 (2004) 1392-1399
16. Subtil C., Guerin E., Schneider A., Chenard M.P., Martin E., Domon-Dell C., Duluc I., Brabletz T., Kedinger M., Duclos B., Gaub M.P., and Freund J.N. Frequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instability. Cancer Lett. 247 (2007) 197-203
17. Brabletz T., Spaderna S., Kolbe J., Hlubek F., Faller G., Bruns C., Jung A., Nentwich J., Duluc I., Domon-Dell C., Kirchner T., and Freund J.N. Downregulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: active role of the tumor environment for malignant tumor progression. Cancer Res. 64 (2004) 6973-6977
18. Domon-Dell C., Schneider A., Moucadel V., Guerin E., Guenot D., Aguillon S., Duluc I., Martin E., Iovanna J., Launay J.F., Duclos B., Chenard M.P., Meyer C., Oudet P., Kedinger M., Gaub M.P., and Freund J.N. Cdx1 homeobox gene during human colon cancer progression. Oncogene 22 (2003) 7913-7921
19. Yagi O.K., Akiyama Y., and Yuasa Y. Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas, Br. J. Cancer 79 (1999) 440-444
20. Hinoi T., Loda M., and Fearon E.R. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J. Biol. Chem. 278 (2003) 44608-44616
21. Benahmed F., Gross I., Guenot D., Jehan F., Martin E., Domon-Dell C., Brabletz T., Kedinger M., Freund J.N., and Duluc I. The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells. Am. J. Pathol. 170 (2007) 733-744
22. Domon-Dell C., and Freund J.N. Stimulation of Cdx1 by oncogenic β-catenin/Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein. FEBS Lett. 518 (2002) 83-87
23. Lorentz O., Cadoret A., Duluc I., Capeau J., Gespach C., Cherqui G., and Freund J.N. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras. Oncogene 18 (1999) 87-92
24. Suh E.R., Ha C.S., Rankin E.B., Toyota M., and Traber P.G. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. J. Biol. Chem. 277 (2002) 35795-35800
25. Aoki K., Tamai Y., Horiike S., Oshima M., and Taketo M.M. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc(+/Delta716) Cdx2(+/-) compound mutant mice. Nat. Genet. 35 (2003) 323-330
26. Gross I., Duluc I., Benameur T., Calon A., Martin E., Brabletz T., Kedinger M., Domon-Dell C., and Freund J.N. The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells. Oncogene 27 (2008) 107-115
27. Haigis K., Sage J., Glickman J., Shafer S., and Jacks T. The related retinoblastoma (pRb) and p130 proteins cooperate to regulate homeostasis in the intestinal epithelium. J. Biol. Chem. 281 (2006) 638-647
28. Blaise S., Alberto J.M., Nedelec E., Ayav A., Pourie G., Bronowicki J.P., Gueant J.L., and Daval J.L. Mild neonatal hypoxia exacerbates the effects of vitamin-deficient diet on homocysteine metabolism in rats. Pediatr. Res. 57 (2005) 777-782
29. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta Ct) method. Methods 25 (2001) 402-408
30. Gross I., Lhermitte B., Domon-Dell C., Duluc I., Martin E., Gaiddon C., Kedinger M., and Freund J.N. Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation. Oncogene 24 (2005) 7955-7963
31. Wong N.A., Britton M.P., Choi G.S., Stanton T.K., Bicknell D.C., Wilding J.L., and Bodmer W.F. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 574-579
32. Guo M.Z., House M.G., Suzuki H., Ye Y., Brock M.V., Lu F., Liu Z., Rustgi A.K., and Herman J.G. Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer. Int. J. Cancer 121 (2007) 1219-1226
33. Liu T., Zhang X., So C.K., Wang S., Wang P., Yan L., Myers R., Chen Z., Patterson A.P., Yang C.S., and Chen X. Regulation of Cdx2 expression by promoter methylation and effects of cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. Carcinogenesis 28 (2007) 488-496